Glenmark Generics gets final ANDA approval for meprazole DR Capsules
From USFDA
Glenmark Generics announced that its US subsidiary, Glenmark Generics Inc. has been granted final approval for its abbreviated new drug application (ANDA) from the United States Food & Drug Administration (USFDA) for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca.Powered by Capital Market - Live News